… % CI, 10 to 12 months) median survival time for the patients whose primary tumor was not
found. However, the log-rank comparison of these survival curves demonstrated a statistically …

… analysis on overall survival was performed to determine the independent influence of
relevant patient and tumour characteristics. Survival time was defined as the time from diagnosis …

… The study by Muñana and Luttgen (1998) had a lower median survival time to our study,
which might reflect the fact that only dogs with a histological diagnosis were included and …

… factors in patients with cervical metastases of unknown origin, we analyzed retrospectively
all pa… mean survival times were calculated using the Kaplan– Meier method and the survival …

… of unknown origin (MUO) treated with prednisolone and ciclosporin and to assess the
effect of a number of patient variables on survival time and rate of relapse. …

… pathophysiology of MUO remain unknown. Several treatment … , to evaluate long-term survival
time in many dogs diagnosed … cerebrospinal fluid analysis on survival time. Dogs included …

Tumors of unknown primary origin account for five to 10 percent of all cancers. Relatively …
rates and had a negligible effect on survival, thereby strengthening arguments for a nihilistic …

… As a group, reported median survival times range from 4 to 11 months and most patients
do not respond to chemotherapy.' However, subgroups of UPC patients have been described …

… , including improved recognition of the tumour origin, thus lowering the number of patients
with the diagnosis of liver metastases of unknown origin (LMUO). The improved detection …

… The median survival time of patients presenting with MUO and … However, the median survival
time of patients presenting with … The median survival time of patients presenting with MUO …